/OSSD.ST
OSSD.ST Stock - OssDsign AB (publ)
Healthcare|Medical - DevicesSTO
$11.46-1.21%
$0.14 (-1.21%) • Dec 23
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.26
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.76
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $12.61
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OSSD.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$11.35 – $11.57
TARGET (TP)$13.18
STOP LOSS$10.54
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.09
52W High$16.72
52W Low$9.76
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $133.94M | $112.16M | $56.98M | $31.73M | $24.87M |
| Gross Profit | $127.75M | $83.64M | $45.13M | $20.84M | $16.00M |
| Gross Margin | 95.4% | 74.6% | 79.2% | 65.7% | 64.3% |
| Operating Income | $-49,426,000 | $-91,956,000 | $-90,493,000 | $-89,701,000 | $-83,934,000 |
| Net Income | $-49,657,000 | $-130,493,000 | $-99,387,000 | $-93,918,000 | $-84,590,000 |
| Net Margin | -37.1% | -116.3% | -174.4% | -296.0% | -340.1% |
| EPS | $-0.50 | $-1.59 | $-1.70 | $-1.94 | $-3.36 |
Company Overview
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. The company's products include OSSDSIGN cranial, an implant solution and related accessories for skull defect reconstruction in cranioplasty patients; and OSSDSIGN facial to treat post-traumatic skeletal deformities and congenital skeletal defects. It also offers OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage; and OssDsign Catalyst, a nanosynthetic bone graft substitute that stimulates the formation of healthy bone tissue. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
OSSD.STBeat Rate
50%
Last 12 quarters
Avg Surprise
+7.0%
EPS vs Estimate
Beats / Misses
6/6
Last 12 quarters
Latest EPS
$-0.05
Q4 2025
EPS Surprise History
Q1 24
-3.4%
$-0.60vs$-0.58
Q2 24
+28.7%
$-0.11vs$-0.16
Q3 24
-0.4%
$-0.16vs$-0.16
Q4 24
+37.5%
$-0.10vs$-0.16
Q1 25
-2.9%
$-0.13vs$-0.13
Q2 25
+17.1%
$-0.15vs$-0.18
Q3 25
-11.1%
$-0.10vs$-0.09
Q4 25
+41.8%
$-0.05vs$-0.09
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 3, 2026 | — | — | — | — |
Q4 2025 | Nov 4, 2025 | $-0.09 | $-0.05 | +41.8% | ✓ BEAT |
Q3 2025 | Aug 19, 2025 | $-0.09 | $-0.10 | -11.1% | ✗ MISS |
Q2 2025 | May 6, 2025 | $-0.18 | $-0.15 | +17.1% | ✓ BEAT |
Q1 2025 | Feb 4, 2025 | $-0.13 | $-0.13 | -2.9% | ✗ MISS |
Q4 2024 | Nov 12, 2024 | $-0.16 | $-0.10 | +37.5% | ✓ BEAT |
Q3 2024 | Aug 20, 2024 | $-0.16 | $-0.16 | -0.4% | ✗ MISS |
Q2 2024 | May 14, 2024 | $-0.16 | $-0.11 | +28.7% | ✓ BEAT |
Q1 2024 | Feb 6, 2024 | $-0.58 | $-0.60 | -3.4% | ✗ MISS |
Q4 2023 | Nov 21, 2023 | — | $-0.37 | — | — |
Q3 2023 | Aug 22, 2023 | — | $-0.28 | — | — |
Q2 2023 | May 23, 2023 | — | $-0.33 | — | — |
Q1 2023 | Feb 21, 2023 | $-0.34 | $-0.50 | -47.1% | ✗ MISS |
Q4 2022 | Nov 22, 2022 | $-0.38 | $-0.30 | +21.1% | ✓ BEAT |
Q3 2022 | Aug 23, 2022 | $-0.39 | $-0.40 | -2.6% | ✗ MISS |
Q2 2022 | May 24, 2022 | $-0.42 | $-0.40 | +4.8% | ✓ BEAT |
Q1 2022 | Feb 22, 2022 | — | $-0.48 | — | — |
Q4 2021 | Nov 17, 2021 | — | $-0.30 | — | — |
Q3 2021 | Aug 18, 2021 | — | $-0.40 | — | — |
Latest News
Loading news...
Frequently Asked Questions about OSSD.ST
What is OSSD.ST's current stock price?
OssDsign AB (publ) (OSSD.ST) is currently trading at $11.46 per share. The stock has moved -1.21% today.
What is the analyst price target for OSSD.ST?
No analyst price targets are currently available for this stock.
What sector is OssDsign AB (publ) in?
OssDsign AB (publ) operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the STO exchange.
What is OSSD.ST's market cap?
OssDsign AB (publ) has a market capitalization of $1.27 billion, making it a small-cap company.
Does OSSD.ST pay dividends?
No, OssDsign AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBICO.ST
BICO Group AB (publ)
$19.00
Mkt Cap: $1.3B
CRAD-B.ST
C-Rad AB (publ)
$31.85
Mkt Cap: $1.0B
DMYD-B.ST
Diamyd Medical AB (publ)
$10.08
Mkt Cap: $1.4B
GENO.ST
Genovis AB (publ.)
$21.20
Mkt Cap: $1.4B
ONCO.ST
Oncopeptides AB (publ)
$4.57
Mkt Cap: $1.0B
PAX.ST
Paxman AB (publ)
$54.00
Mkt Cap: $1.3B
SEDANA.ST
Sedana Medical AB (publ)
$9.92
Mkt Cap: $1.0B
SEZI.ST
Senzime AB (publ)
$5.26
Mkt Cap: $0.8B
STIL.ST
Stille AB
$208.00
Mkt Cap: $1.9B
SYNACT.ST
SynAct Pharma AB
$23.80
Mkt Cap: $1.3B
Explore stocks similar to OSSD.ST for comparison